Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events.
Shimomura H, Ogawa H, Takazoe K, Soejima H, Miyamoto S, Sakamoto T, Kawano H, Suefuji H, Nishikawa H, Arai H, Hokamaki J, Kajiwara I, Kugiyama K, Yoshimura M. Shimomura H, et al. Am J Cardiol. 2002 Jul 15;90(2):108-11. doi: 10.1016/s0002-9149(02)02430-x. Am J Cardiol. 2002. PMID: 12106837 Clinical Trial.
Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: comparison with unfractionated heparin.
Sakamoto T, Ogawa H, Takazoe K, Yoshimura M, Shimomura H, Moriyama Y, Arai H, Okajima K. Sakamoto T, et al. Among authors: shimomura h. J Am Coll Cardiol. 2003 Oct 15;42(8):1389-94. doi: 10.1016/s0735-1097(03)01059-3. J Am Coll Cardiol. 2003. PMID: 14563580 Free article. Clinical Trial.
Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese.
Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, Sakaino N, Kitagawa A; Multicenter Study for Aggressive Lipid-Lowering Strategy by HMG-CoA Reductase Inhibitors in Patients With Acute Myocardial Infarction Investigators. Sakamoto T, et al. Among authors: shimomura h. Am J Cardiol. 2006 Apr 15;97(8):1165-71. doi: 10.1016/j.amjcard.2005.11.031. Epub 2006 Mar 10. Am J Cardiol. 2006. PMID: 16616020 Clinical Trial.
Long-term efficacy of edaravone in patients with acute myocardial infarction.
Tsujita K, Shimomura H, Kaikita K, Kawano H, Hokamaki J, Nagayoshi Y, Yamashita T, Fukuda M, Nakamura Y, Sakamoto T, Yoshimura M, Ogawa H. Tsujita K, et al. Among authors: shimomura h. Circ J. 2006 Jul;70(7):832-7. doi: 10.1253/circj.70.832. Circ J. 2006. PMID: 16799234 Free article. Clinical Trial.
Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Matsukawa M, Kaikita K, Soejima K, Fuchigami S, Nakamura Y, Honda T, Tsujita K, Nagayoshi Y, Kojima S, Shimomura H, Sugiyama S, Fujimoto K, Yoshimura M, Nakagaki T, Ogawa H. Matsukawa M, et al. Among authors: shimomura h. Am J Cardiol. 2007 Sep 1;100(5):758-63. doi: 10.1016/j.amjcard.2007.03.095. Epub 2007 Jun 12. Am J Cardiol. 2007. PMID: 17719316
Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.
Nakamura Y, Yamada Y, Shimomura H, Nagayoshi Y, Tsujita K, Yamashita T, Fukuda M, Ohba K, Nako H, Ogura Y, Chitose T, Yamaguchi M, Nagata T, Soejima H, Kaikita K, Sugiyama S, Ogawa H. Nakamura Y, et al. Among authors: shimomura h. J Cardiol. 2009 Dec;54(3):416-24. doi: 10.1016/j.jjcc.2009.07.001. Epub 2009 Aug 20. J Cardiol. 2009. PMID: 19944317 Free article. Clinical Trial.
Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
Sakamoto T, Ogawa H, Nakao K, Hokimoto S, Tsujita K, Koide S, Yamamoto N, Shimomura H, Matsumura T, Oshima S, Kikuta K, Oka H, Kimura K, Matsui K; 4C (Candesartan for Prevention of Cardiovascular Events after CYPHER™ or TAXUS™ Coronary Stenting) study investigators. Sakamoto T, et al. Among authors: shimomura h. J Cardiol. 2016 Apr;67(4):371-7. doi: 10.1016/j.jjcc.2015.06.009. Epub 2015 Aug 4. J Cardiol. 2016. PMID: 26254019 Free article. Clinical Trial.
Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases - INVITATION trial.
Fujisue K, Shirakawa T, Nakamura S, Yamamoto N, Oshima S, Matsumura T, Tsunoda R, Hirai N, Tayama S, Nakamura N, Hirose T, Maruyama H, Fujimoto K, Kajiwara I, Sakamoto T, Nakao K, Sakaino N, Hokimoto S, Nagayoshi Y, Hokamaki J, Shimomura H, Sakamoto K, Yamamoto E, Izumiya Y, Kaikita K, Ogawa H, Tsujita K; INVITATION study investigators. Fujisue K, et al. Among authors: shimomura h. J Cardiol. 2018 Oct;72(4):350-355. doi: 10.1016/j.jjcc.2018.03.012. Epub 2018 May 4. J Cardiol. 2018. PMID: 29735336 Free article.
429 results